Healthcare provider profile · identity verified

Solimayli Rivera, M.D.

General Practice · AGUADA, PR · NPI 1538139340

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	607	86
Gabapentin	Gabapentin	538	62
Metformin Hcl	Metformin Hcl	486	61
Lisinopril	Lisinopril	468	56
Amlodipine Besylate	Amlodipine Besylate	465	58
Simvastatin	Simvastatin	354	45
Synthroid	Levothyroxine Sodium	310	35
Losartan Potassium	Losartan Potassium	296	39
Omeprazole	Omeprazole	282	35
Famotidine	Famotidine	270	33
Rosuvastatin Calcium	Rosuvastatin Calcium	217	33
Tamsulosin Hcl	Tamsulosin Hcl	208	24
Glipizide	Glipizide	191	27
Meloxicam	Meloxicam	186	40
Metoprolol Succinate	Metoprolol Succinate	182	22
Alendronate Sodium	Alendronate Sodium	180	21
Hydrochlorothiazide	Hydrochlorothiazide	165	17
Clopidogrel	Clopidogrel Bisulfate	158	19
Pantoprazole Sodium	Pantoprazole Sodium	154	24
Atenolol	Atenolol	139	16
Farxiga	Dapagliflozin Propanediol	131	14
Montelukast Sodium	Montelukast Sodium	107	15
Amitriptyline Hcl	Amitriptyline Hcl	101	12
Metoprolol Tartrate	Metoprolol Tartrate	101	14
Albuterol Sulfate Hfa	Albuterol Sulfate	99	15
Clonazepam	Clonazepam	97	11
Lantus	Insulin Glargine,hum.Rec.Anlog	96	11
Carvedilol	Carvedilol	93	suppressed
Sulindac	Sulindac	93	18
Doxazosin Mesylate	Doxazosin Mesylate	87	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	87	11
Irbesartan	Irbesartan	86	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	86	suppressed
Furosemide	Furosemide	85	suppressed
Tizanidine Hcl	Tizanidine Hcl	85	13
Levothyroxine Sodium	Levothyroxine Sodium	81	12
Donepezil Hcl	Donepezil Hcl	80	11
Nabumetone	Nabumetone	75	13
Fluticasone Propionate	Fluticasone Propionate	70	29
Diclofenac Sodium	Diclofenac Sodium	68	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	64	suppressed
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	60	suppressed
Duloxetine Hcl	Duloxetine Hcl	59	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	59	suppressed
Enalapril Maleate	Enalapril Maleate	58	suppressed
Ibandronate Sodium	Ibandronate Sodium	55	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	54	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	49	suppressed
Latanoprost	Latanoprost	49	suppressed
Spironolactone	Spironolactone	48	suppressed
Naproxen	Naproxen	40	suppressed
Nifedipine Er	Nifedipine	40	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	39	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	38	13
Temazepam	Temazepam	37	suppressed
Prednisone	Prednisone	36	suppressed
Insulin Glargine	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Propranolol Hcl	Propranolol Hcl	33	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	30	suppressed
Alprazolam	Alprazolam	29	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	29	suppressed
Ibuprofen	Ibuprofen	29	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	29	suppressed
Leflunomide	Leflunomide	29	suppressed
Lorazepam	Lorazepam	28	suppressed
Methotrexate	Methotrexate Sodium	28	suppressed
Sucralfate	Sucralfate	26	suppressed
Verapamil Er	Verapamil Hcl	26	suppressed
Glimepiride	Glimepiride	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Sertraline Hcl	Sertraline Hcl	24	suppressed
Sure Comfort	Syringe And Needle,insulin,1ml	24	suppressed
Brilinta	Ticagrelor	23	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	22	suppressed
Insulin Lispro	Insulin Lispro	22	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	22	suppressed
Azithromycin	Azithromycin	20	18
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	19	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Dexlansoprazole Dr	Dexlansoprazole	18	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	18	suppressed
Timolol Maleate	Timolol Maleate	18	suppressed
Tramadol Hcl	Tramadol Hcl	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Celecoxib	Celecoxib	17	suppressed
Sure Comfort	Syring-Needl,disp,insul,0.3 Ml	17	suppressed
Glipizide Er	Glipizide	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Azelastine-Fluticasone	Azelastine/Fluticasone	15	suppressed
Calcitriol	Calcitriol	15	suppressed
Ciclopirox	Ciclopirox	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Ciclopirox	Ciclopirox Olamine	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	14
Etodolac	Etodolac	14	suppressed
Humulin N	Insulin Nph Human Isophane	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Leucovorin Calcium	Leucovorin Calcium	13	suppressed
Pentoxifylline	Pentoxifylline	13	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Advocate Syringes	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Anastrozole	Anastrozole	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Cyclosporine	Cyclosporine	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error